MENU
+Compare
QNRX
Stock ticker: NASDAQ
AS OF
Jan 17 closing price
Price
$0.57
Change
-$0.02 (-3.39%)
Capitalization
4.68M

QNRX Quoin Pharmaceuticals Ltd Forecast, Technical & Fundamental Analysis

a developer of biological products for cellular therapies

Industry Biotechnology
QNRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for QNRX with price predictions
Jan 08, 2025

QNRX sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for QNRX moved above the 200-day moving average on December 19, 2024. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 30, 2024. You may want to consider a long position or call options on QNRX as a result. In of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for QNRX just turned positive on January 02, 2025. Looking at past instances where QNRX's MACD turned positive, the stock continued to rise in of 38 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where QNRX advanced for three days, in of 210 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 28 cases where QNRX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

QNRX moved below its 50-day moving average on January 06, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for QNRX crossed bearishly below the 50-day moving average on December 20, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where QNRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for QNRX entered a downward trend on January 02, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.859) is normal, around the industry mean (14.746). P/E Ratio (0.000) is within average values for comparable stocks, (88.252). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.853). QNRX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.000) is also within normal values, averaging (264.084).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. QNRX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. QNRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
QNRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

QNRX is expected to report earnings to fall 88.50% to -24 cents per share on November 09

Quoin Pharmaceuticals Ltd QNRX Stock Earnings Reports
Q3'23
Est.
$-0.25
Q2'23
Beat
by $0.69
Q1'23
Missed
by $3.81
Q4'22
Beat
by $0.10
Q3'22
Missed
by $9.93
The last earnings report on August 02 showed earnings per share of -213 cents, beating the estimate of -281 cents. With 117.66K shares outstanding, the current market capitalization sits at 4.68M.
A.I. Advisor
published General Information

General Information

a developer of biological products for cellular therapies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
42127 Pleasant Forest Court
Phone
+1 703 980-4182
Employees
4
Web
https://www.quoinpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CMBM1.030.05
+5.10%
Cambium Networks Corp
EWBC100.801.31
+1.32%
East West Bancorp
BATRK37.580.22
+0.59%
Atlanta Braves Holdings
AUTL2.22N/A
N/A
Autolus Therapeutics plc
PALI1.48-0.18
-10.84%
Palisade Bio

QNRX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, QNRX has been loosely correlated with ATNM. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if QNRX jumps, then ATNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNRX
1D Price
Change %
QNRX100%
-3.12%
ATNM - QNRX
35%
Loosely correlated
+14.75%
WVE - QNRX
31%
Poorly correlated
-2.83%
ATNF - QNRX
30%
Poorly correlated
-1.27%
MRNA - QNRX
28%
Poorly correlated
+0.89%
AADI - QNRX
26%
Poorly correlated
-4.79%
More